GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » COGS-to-Revenue

Inventage Lab (XKRX:389470) COGS-to-Revenue : 0.01 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab COGS-to-Revenue?

Inventage Lab's Cost of Goods Sold for the three months ended in Mar. 2024 was ₩1.3 Mil. Its Revenue for the three months ended in Mar. 2024 was ₩96.9 Mil.

Inventage Lab's COGS to Revenue for the three months ended in Mar. 2024 was 0.01.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Inventage Lab's Gross Margin % for the three months ended in Mar. 2024 was 98.63%.


Inventage Lab COGS-to-Revenue Historical Data

The historical data trend for Inventage Lab's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab COGS-to-Revenue Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
- - 0.13 0.11 0.11

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 - - 0.16 0.01

Inventage Lab COGS-to-Revenue Calculation

Inventage Lab's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=74.381 / 658.152
=0.11

Inventage Lab's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.327 / 96.928
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inventage Lab  (XKRX:389470) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Inventage Lab's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1.327 / 96.928
=98.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Inventage Lab COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Inventage Lab's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventage Lab (XKRX:389470) Business Description

Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines